Lexicon Pharmaceuticals (LXRX) Retained Earnings: 2009-2012
Historic Retained Earnings for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to -$875.0 million.
- Lexicon Pharmaceuticals' Retained Earnings fell 15.77% to -$875.0 million in Q3 2012 from the same period last year, while for Sep 2012 it was -$875.0 million, marking a year-over-year decrease of 15.77%. This contributed to the annual value of -$789.6 million for FY2011, which is 17.26% down from last year.
- According to the latest figures from Q3 2012, Lexicon Pharmaceuticals' Retained Earnings is -$875.0 million, which was down 3.49% from -$845.4 million recorded in Q2 2012.
- In the past 5 years, Lexicon Pharmaceuticals' Retained Earnings ranged from a high of -$509.0 million in Q1 2009 and a low of -$875.0 million during Q3 2012.
- Moreover, its 3-year median value for Retained Earnings was -$729.7 million (2011), whereas its average is -$732.9 million.
- Data for Lexicon Pharmaceuticals' Retained Earnings shows a maximum YoY decreased of 18.65% (in 2010) over the last 5 years.
- Over the past 4 years, Lexicon Pharmaceuticals' Retained Earnings (Quarterly) stood at -$570.2 million in 2009, then decreased by 18.11% to -$673.4 million in 2010, then decreased by 17.26% to -$789.6 million in 2011, then fell by 15.77% to -$875.0 million in 2012.
- Its last three reported values are -$875.0 million in Q3 2012, -$845.4 million for Q2 2012, and -$819.5 million during Q1 2012.